Affluent Medical strengthens its management team to
supporting industrial and commercial deployment
Aix-en-Provence, January 16, 2023 – 5:45 p.m. – Affluent Medical (ISIN code: FR0013333077 – mnemonic
: AFME), French medtech specializing in the international development and industrialization of
innovative, clinical-stage medical prostheses to treat urinary incontinence and
cardiac mitral valve pathology announcement, following the strengthening of the clinical team with
the arrival of Christophe Giot VP clinical affairs in the second half of 2022, the recruitment of three members of the
management committee to prepare the next stages of industrialization then commercialization of these
three innovative medical devices, Kalios, Artus and Epygon.